As more states and countries legalize marijuana, it stands to reason that more people are using the drug for medical and recreational reasons. In fact, a recent Gallup survey found...

The need for innovative science to address type 1 diabetes only grows more urgent. The JDRF counts 1.6 million people living with the disease in the U.S., and that number is increasing...

Jodi Cruz never expected to be this healthy, or this lucky, or possibly even alive, by now.   That’s because the 45-year-old mother of three from Irvine, California, had struggled...

Biochemist Charles Brenner, Ph.D., has joined City of Hope to lead the nation’s first research department focused on the intersection between cancer and diabetes. He is also the inaugural holder...

At a recent virtual symposium — “Diabetes and Cancer Interface: Connecting the Dots” — City of Hope gynecologic cancer expert Lorna Rodríguez-Rodriguez, M.D., Ph.D., issued a call to arms of...

During her more than 30 years at City of Hope, Joyce Niland, Ph.D., the Estelle & Edward Alexander Chair in Information Sciences, has helped design, build and operate City of...

With the coronavirus devastatingly resurgent this fall and cases spiking in areas previously untouched by the ravages of the pandemic, millions of people with underlying conditions know that they must...

Bart Roep, Ph.D. An innovative, first-of-its kind vaccine that uses a person’s own immune cells and vitamin D3 to treat type 1 diabetes is both safe and feasible, according to research...

For Charles Brenner, Ph.D., it’s all about the questions.   “I want to ask the question nobody else will ask,” he said. “We generally don’t know what we don’t know...

From a certain vantage, the quest to defeat diabetes encompasses more than just one disease. Diabetes can affect many systems in the body over time, with complications potentially arising in...